Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Change in Account Payables (2022 - 2025)

Historic Change in Account Payables for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to -$47000.0.

  • PAVmed's Change in Account Payables changed N/A to -$47000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$125000.0, marking a year-over-year change of. This contributed to the annual value of -$59000.0 for FY2024, which is 9357.3% up from last year.
  • According to the latest figures from Q3 2025, PAVmed's Change in Account Payables is -$47000.0.
  • In the past 5 years, PAVmed's Change in Account Payables registered a high of $3.9 million during Q1 2022, and its lowest value of -$2.9 million during Q2 2022.
  • In the last 4 years, PAVmed's Change in Account Payables had a median value of -$174500.0 in 2023 and averaged -$167000.0.
  • In the last 5 years, PAVmed's Change in Account Payables tumbled by 25899.58% in 2023 and then soared by 15000.0% in 2024.
  • Quarter analysis of 4 years shows PAVmed's Change in Account Payables stood at $239000.0 in 2022, then plummeted by 259.0% to -$380000.0 in 2023, then skyrocketed by 150.0% to $190000.0 in 2024, then crashed by 124.74% to -$47000.0 in 2025.
  • Its Change in Account Payables stands at -$47000.0 for Q3 2025, versus $18000.0 for Q2 2025 and -$286000.0 for Q1 2025.